NCT01741688View on ClinicalTrials.gov

An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2012

Primary Completion Date

March 6, 2014

Study Completion Date

March 6, 2014

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

Tocilizumab

Tocilizumab was administered according to the local label.

Trial Locations (4)

Lima 21

ABK Reuma SRL- Medicentro BioCiencias, Lima

Lima 34

Hospital de la Mujer, Lima

Lima 41

Clinica San Borja; Servicio De Reumatologia, Lima

L27 Lima

Clinica El Golf, San Isidro

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT01741688 - An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter